Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.32 |
| ▸ | HTR6 | P50406 | 2/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR7 | P34969 | 1/20 | 0.31 |
| ▸ | HTR5A | P47898 | 1/20 | 0.31 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20009766 | 1.00 | KDM4E (0.38) | KDM4EATML3MBTL1ALDH1A1TSPO | |
| SCHEMBL24902255 | 0.99 | KDM4E (0.37) | KDM4EATML3MBTL1ALDH1A1TSPO | |
| SCHEMBL24902533 | 0.97 | KDM4E (0.40) | KDM4EATML3MBTL1ALDH1A1TSPO | |
| SCHEMBL24902253 | 0.96 | KDM4E (0.39) | KDM4EATML3MBTL1ALDH1A1TSPO | |
| SCHEMBL24902285 | 0.94 | KDM4E (0.35) | KDM4EATML3MBTL1ALDH1A1TSPO | |
| SCHEMBL24844518 | 0.93 | ATM (0.39) | KDM4EATML3MBTL1ALDH1A1TSPO | |
| SCHEMBL24902526 | 0.93 | ATM (0.39) | KDM4EATML3MBTL1ALDH1A1TSPO | |
| SCHEMBL20812943 | 0.93 | ATM (0.39) | KDM4EATML3MBTL1ALDH1A1TSPO | |
| SCHEMBL24903062 | 0.93 | ATM (0.39) | KDM4EATML3MBTL1ALDH1A1TSPO | |
| SCHEMBL24903191 | 0.93 | KDM4E (0.43) | KDM4EATML3MBTL1ALDH1A1TSPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230023811-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO.,LTD. (JP) | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230023811-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE | PIEZO1, LEF1, TMEM109 | KDM4E 2255/4885ATM 2485/4885L3MBTL1 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.